Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
11 - 20 out of 63Page size: 10
  1. 2023
  2. Published

    The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Helleberg, C., Hermansen, E., Bønløkke, S. T., Nielsen, K., Teodorescu, E. M., Kurt, E., Strandholdt, C. N. & Vangsted, Annette Juul, 2023, In: eJHaem. 4, 4, p. 1006-1012 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

    van de Donk, N. W. C. J., Minnema, M. C., van der Holt, B., Schjesvold, F., Wu, K. L., Broijl, A., Roeloffzen, W. W. H., Gadisseur, A., Pietrantuono, G., Pour, L., van der Velden, V. H. J., Lund, T., Offidani, M., Grasso, M., Giaccone, L., Razawy, W., Tacchetti, P., Mancuso, K., Silkjaer, T., Caers, J. & 8 others, Zweegman, S., Hájek, R., Benjamin, R., Vangsted, Annette Juul, Boccadoro, M., Gay, F., Sonneveld, P. & Musto, P., 2023, In: The Lancet Oncology. 24, 10, p. 1119-1133 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2022
  5. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    MacAuda, A., Clay-Gilmour, A., Hielscher, T., Hildebrandt, M. A. T., Kruszewski, M., Orlowski, R. Z., Kumar, S. K., Ziv, E., Orciuolo, E., Brown, E. E., Försti, A., Waller, R. G., MacHiela, M. J., Chanock, S. J., Camp, N. J., Rymko, M., Raźny, M., Cozen, W., Várkonyi, J., Piredda, C. & 36 others, Pelosini, M., Belachew, A. A., Subocz, E., Hemminki, K., Rybicka-Ramos, M., Giles, G. G., Milne, R. L., Hofmann, J. N., Zaucha, J. M. I., Vangsted, Annette Juul, Goldschmidt, H., Rajkumar, S. V., Tomczak, W., Sainz, J., Butrym, A., Watek, M., Iskierka-Jazdzewska, E., Buda, G., Robinson, D. P., Jurczyszyn, A., Dudzinski, M., Martinez-Lopez, J., Sinnwell, J. P., Slager, S. L., Jamroziak, K., Reis, R. M. V., Weinhold, N., Bhatti, P., Carvajal-Carmona, L. G., Zawirska, D., Norman, A. D., Mazur, G., Berndt, S. I., Campa, D., Vachon, C. M. & Canzian, F., 2022, In: Cancer Epidemiology Biomarkers and Prevention. 31, 9, p. 1863-1866

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

    Blimark, C. H., Vangsted, Annette Juul, Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), T. R. E. G. W. T. N. M. S. G. (., 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, Annette Juul, 2022, In: American Journal of Hematology. 97, 3, p. E117-E120

    Research output: Contribution to journal › Letter › Research › peer-review

  10. Published

    The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease

    Richardson, P. G., Mateos, M. V., Vangsted, Annette Juul, Ramasamy, K., Abildgaard, N., Ho, P. J., Quach, H. & Bahlis, N. J., 2022, In: Expert Review of Proteomics. 19, 4-6, p. 235-246

    Research output: Contribution to journal › Review › Research › peer-review

  11. 2021
  12. Published

    Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    Melaiu, O., Macauda, A., Sainz, J., Calvetti, D., Facioni, M. S., Maccari, G., ter Horst, R., Netea, M. G., Li, Y., Grząśko, N., Moreno, V., Jurczyszyn, A., Jerez, A., Watek, M., Varkonyi, J., Garcia-Sanz, R., Kruszewski, M., Dudziński, M., Kadar, K., Jacobsen, S. E. H. & 34 others, Mazur, G., Andersen, V., Rybicka, M., Zawirska, D., Raźny, M., Zaucha, J. M., Ostrovsky, O., Iskierka-Jazdzewska, E., Reis, R. M., Stępień, A., Beider, K., Nagler, A., Druzd-Sitek, A., Marques, H., Martìnez-Lopez, J., Lesueur, F., Avet-Loiseau, H., Vangsted, Annette Juul, Krawczyk-Kulis, M., Butrym, A., Jamroziak, K., Dumontet, C., Vogel, U., Rymko, M., Pelosini, M., Subocz, E., Szombath, G., Sarasquete, M. E., Silvestri, R., Morani, F., Landi, S., Campa, D., Canzian, F. & Gemignani, F., 15 Apr 2021, In: International Journal of Cancer. 148, 8, p. 1887-1894 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

    Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G. & 4 others, Boccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., 2021, In: Haematologica. 106, 11, p. 2799-2812

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 9762536